Drugs / MenACWY Ad+
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00262002 | Sep 2004 → Jul 2005 | meningococcemia | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MenACWY Ad+ | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00262002 ↗ |
| Known as | MenACWY-CRM | “MenACWY Ad+ (MenACWY-CRM, adjuvanted formulation)” NCT00262002 ↗ |
| Modality | Vaccine | “MenACWY-CRM conjugate vaccine formulated with adjuvant” NCT00262002 ↗ |
| Route | Intramuscular | “was injected IM in the anterolateral area of the right thigh” NCT00262002 ↗ |